Zeynep Arzu Yegin

12PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesMedical bacteriologyPredictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 27, 2026
Is Consolidation Therapy Effective in Multiple Myeloma Patients after High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Single Center Real-Life Data with Cyclophosphamide-Bortezomib-Dexamethasone or Bortezomib-Lenalidomide-Dexamethasone?

|Mar 07, 2026
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study.

Malgorzata Mikulska, Gloria Tridello, Per Ljungman

|Jan 19, 2026
Etiological Agents of Bacteremia in Patients with Hematological Malignancies: Evaluation of 18 Years of Data.

Özge Özgen Top, Pınar Aysert Yıldız, Fatma Güçlü

|Oct 14, 2025
C-Reactive Protein/Albumin Ratio (CAR) Predicts Early Posttransplant Complications and Survival in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Şeyma Yıldız, Zeynep Arzu Yegin, Gonca Gül Gündem

|Oct 25, 2023
Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.

Başak Bostankolu Değirmenci, Zeynep Arzu Yegin, Ümit Özgür Akdemir

|Oct 03, 2023
Preconditioning Modified-Easix as a Predictor of Prognosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Zeynep Arzu Yegin, Emine Merve Savaş, Şeyma Yıldız

Pageof 2

Frequent Collaborators

9 joint publications

Zübeyde Nur Özkurt

8 joint publications

Münci Yağcı

3 joint publications

Ferda Can

2 joint publications

Gonca Gül Gündem